National Institutes of Health


Sitemap Contact
National Institutes of Health HIPAA Privacy Rule - Information for Researchers
This website is currently in the process of being updated. For guidance on the HIPAA Privacy Rule in research, please see: https://www.hhs.gov/hipaa/for-professionals/special-topics/research/index.html
HomeDictionaryFAQResources

Educational Materials

Clinical Research

Authorizations

Institutional Review Boards

Privacy Boards

Information for Patients

HIPAA Privacy Rule Booklet for Research

Health Services Research and the HIPAA Privacy Rule

Research Repositories, Databases


Slide Presentations

National Institutes of Health
Slide Presentation on the Privacy Rule and Research


Slide 35:
Please see description below for information in image.
< Previous Slide 35 Next >

Public Health Disclosures to a Public Health Authority

  • Disclosure without Authorization permitted to a public health authority and certain other entities for public health activities.
  • EXAMPLE: Adverse event reporting to a person subject to the jurisdiction of FDA (e.g., clinical trials drug sponsor), FDA or NIH (where authorized to receive such reports).
  • A covered entity may disclose PHI related to an adverse event to NIH if required to do so by NIH regulations. Even if not required to do so, the researcher may disclose adverse events to NIH as a public health authority, as noted above.
  • Also see guidance on public health at http://www.cdc.gov/privacyrule/

Department of Health and Human Services National Institutes of Health USAGov The HIPAA Privacy Rule